And regarding the regulatory treatment of the Paul
Post# of 154568
(Total Views: 392)
Posted On: 06/10/2025 10:50:09 AM
And regarding the regulatory treatment of the Paulson shares,
"Regulatory Treatment
The SEC and FINRA would not consider this a reportable short sale under Reg SHO as long as the seller owns the shares and they are deliverable within the T+2 window. And again, shares issued from warrant exercise increase the outstanding share count, so they're not borrowed from existing float."
Whatever, it still must be acknowledged that whether these Paulson share sales (god, I'm sick of hearing about them, it will be so great to see them gone) are truly short or not, they are sales and will depress the share price. I guess where I get off is the notion that the price action we're seeing is all about the Paulson shares. While there are some day traders in the mix as well, looking at the chart it's pretty obvious there's predatory shorting and price-fixing at work here with the help of (hell maybe because of) the market makers in the stock.
"Regulatory Treatment
The SEC and FINRA would not consider this a reportable short sale under Reg SHO as long as the seller owns the shares and they are deliverable within the T+2 window. And again, shares issued from warrant exercise increase the outstanding share count, so they're not borrowed from existing float."
Whatever, it still must be acknowledged that whether these Paulson share sales (god, I'm sick of hearing about them, it will be so great to see them gone) are truly short or not, they are sales and will depress the share price. I guess where I get off is the notion that the price action we're seeing is all about the Paulson shares. While there are some day traders in the mix as well, looking at the chart it's pretty obvious there's predatory shorting and price-fixing at work here with the help of (hell maybe because of) the market makers in the stock.
(3)
(0)